Langat virus inhibits the gp130/JAK/STAT signaling by reducing the gp130 protein level. 2024

Shaoli Lin, and Xiaochun Wang, and Bhargava Teja Sallapalli, and Adam Hage, and Peixi Chang, and Jia He, and Sonja M Best, and Yanjin Zhang
Molecular Virology Laboratory, Virginia-Maryland College of Veterinary Medicine, University of Maryland, College Park, MD, USA.

The tick-borne encephalitis virus (TBEV) serocomplex includes several medically important flavivirus members endemic to Europe, Asia, and North America, which can induce severe neuroinvasive or viscerotropic diseases with unclear mechanisms of pathogenesis. Langat virus (LGTV) shares a high sequence identity with TBEV but exhibits lower pathogenic potential in humans and serves as a model for virus-host interactions. In this study, we demonstrated that LGTV infection inhibits the activation of gp130/JAK/STAT (Janus kinases (JAK) and signal transducer and activator of transcription (STAT)) signaling, which plays a pivotal role in numerous biological processes. Our data show that the LGTV-infected cells had significantly lower phosphorylated STAT3 (pSTAT3) protein upon oncostatin M (OSM) stimulation than the mock-infected control. LGTV infection blocked the nuclear translocation of STAT3 without a significant effect on total STAT3 protein level. LGTV inhibited JAK1 activation and reduced gp130 protein expression in infected cells, with the viral NS5 protein mediating this effect. TBEV infection also reduces gp130 level. On the other hand, pretreatment of Vero cells with OSM significantly reduces LGTV replication, and STAT1/STAT2 knockdown had little effect on OSM-mediated antiviral effect, which suggests it is independent of STAT1/STAT2 and, instead, it is potentially mediated by STAT3 signlaing. These findings shed light on the LGTV and TBEV-cell interactions, offering insights for the future development of antiviral therapeutics and improved vaccines.

UI MeSH Term Description Entries

Related Publications

Shaoli Lin, and Xiaochun Wang, and Bhargava Teja Sallapalli, and Adam Hage, and Peixi Chang, and Jia He, and Sonja M Best, and Yanjin Zhang
October 2010, Journal of virology,
Shaoli Lin, and Xiaochun Wang, and Bhargava Teja Sallapalli, and Adam Hage, and Peixi Chang, and Jia He, and Sonja M Best, and Yanjin Zhang
May 2022, Archives of virology,
Shaoli Lin, and Xiaochun Wang, and Bhargava Teja Sallapalli, and Adam Hage, and Peixi Chang, and Jia He, and Sonja M Best, and Yanjin Zhang
April 2024, Journal of medical virology,
Shaoli Lin, and Xiaochun Wang, and Bhargava Teja Sallapalli, and Adam Hage, and Peixi Chang, and Jia He, and Sonja M Best, and Yanjin Zhang
February 2004, IUBMB life,
Shaoli Lin, and Xiaochun Wang, and Bhargava Teja Sallapalli, and Adam Hage, and Peixi Chang, and Jia He, and Sonja M Best, and Yanjin Zhang
February 2003, Genes & development,
Shaoli Lin, and Xiaochun Wang, and Bhargava Teja Sallapalli, and Adam Hage, and Peixi Chang, and Jia He, and Sonja M Best, and Yanjin Zhang
June 1998, Current opinion in immunology,
Shaoli Lin, and Xiaochun Wang, and Bhargava Teja Sallapalli, and Adam Hage, and Peixi Chang, and Jia He, and Sonja M Best, and Yanjin Zhang
October 2010, Virology journal,
Shaoli Lin, and Xiaochun Wang, and Bhargava Teja Sallapalli, and Adam Hage, and Peixi Chang, and Jia He, and Sonja M Best, and Yanjin Zhang
March 2004, Journal of cell science,
Shaoli Lin, and Xiaochun Wang, and Bhargava Teja Sallapalli, and Adam Hage, and Peixi Chang, and Jia He, and Sonja M Best, and Yanjin Zhang
November 2007, Cell,
Shaoli Lin, and Xiaochun Wang, and Bhargava Teja Sallapalli, and Adam Hage, and Peixi Chang, and Jia He, and Sonja M Best, and Yanjin Zhang
June 2016, Cell death & disease,
Copied contents to your clipboard!